SpectraCure
0.09 SEK
-1.50 %
Less than 1K followers
SPEC
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-1.50 %
-41.01 %
-42.20 %
-49.78 %
-47.12 %
-90.02 %
-96.90 %
-98.65 %
-85.28 %
SpectraCure operates in the medical technology sector. The company specializes in research and development of medical technology systems used for the treatment of prostate cancer. The cancer treatments are based on proprietary systems that emit laser light sources and photoreactive drugs, a treatment methodology used for internal solid tumors of various types. The largest operations are found in the Nordic market. The company has its headquarters in Lund.
Read moreMarket cap
52.01M SEK
Turnover
322.21K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27/2
2026
Annual report '25
27/5
2026
Interim report Q1'26
14/8
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
SpectraCure AB tillförs cirka 15,6 MSEK genom teckningsoptioner av serie TO5
SpectraCure tecknar avtal med ytterligare sjukhus i Tyskland för klinisk studie av primär lokaliserad prostatacancer
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools